Dr. Sinha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1450 San Pablo St
Suite 5000
Los Angeles, CA 90033Phone+1 323-442-5790Fax+1 323-442-5820- Is this information wrong?
Summary
- Dr. Uttam Sinha is an otolaryngologist in Los Angeles, CA and is affiliated with Keck Hospital of USC, LAC+USC Medical Center, and USC Norris Comprehensive Cancer Center. He did Research Fellowship in Molecular Oncology and residency in Otolaryngology-Head and Neck Surgery at University of Southern California, Los Angeles. Dr. Sinha completed a clinical fellowship in Microvascular, Plastic and Reconstructive Surgery at Mount Sinai Hospital, New York. He then joined the Department of Otolaryngology-Head and Neck Surgery in 1996 and has been in practice for 23 years. He specializes in head & neck oncological surgery, plastic and reconstructive surgery and is experienced in head and neck oncology, laryngology, early detection of cancer with liquid biopsy and cancer stem cell clinical trials.
Education & Training
- OtherClass of 2012
- University of Southern California/LAC+USC Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 1990 - 1995
- University of Calcutta School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1991 - 2025
- NY State Medical License 1995 - 1997
- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Awards, Honors, & Recognition
- President Elect Society of University Otolaryngologusts-Head and Neck Surgeons
- Fellow (FAAO-HNS) American Academy of Otolaryngology - Head and Neck Surgery
- Fellow (FACS) American College of Surgeons
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors Start of enrollment: 2011 Feb 01
Publications & Presentations
PubMed
- Reciprocal inhibition between TP63 and STAT1 regulates anti-tumor immune response through interferon-γ signaling in squamous cancer.Yuan Jiang, Yueyuan Zheng, Yuan-Wei Zhang, Shuai Kong, Jinxiu Dong, Fei Wang, Benjamin Ziman, Sigal Gery, Jia-Jie Hao, Dan Zhou, Jianian Zhou, Allen S Ho, Uttam K Sinh...> ;Nature Communications. 2024 Mar 20
- Activation of Epstein-Barr Virus' Lytic Cycle in Nasopharyngeal Carcinoma Cells by NEO212, a Conjugate of Perillyl Alcohol and Temozolomide.Hannah Hartman-Houstman, Steve Swenson, Radu O Minea, Uttam K Sinha, Ming-Fu Chiang, Thomas C Chen, Axel H Schönthal> ;Cancers. 2024 Feb 26
- Epigenomic analyses identify FOXM1 as a key regulator of anti-tumor immune response in esophageal adenocarcinoma.Ziman, B., Yang, Q., Zheng, Y., Sheth, M., Nam, C., Zhao, H., Zhang, L., Hu, B., Bhowmick, N., Lin, D., Sinha, U.> ;Cell Death & Disease. 2024 Feb 19
- Join now to see all
Journal Articles
- Rapidly Enlarging Parapharyngeal MassUttam Sinha, MD, JAMA Psychiatry
Press Mentions
- Residents Medical Amasses a Dream Team Consisting of Deans, Chief Residents, MDs and PhDs to Help Medical Residency CandidatesMay 14th, 2018
Professional Memberships
- Fellow
- Member
- Fellow
- Member
- Fellow
Hospital Affiliations
- Keck Hospital of USCLos Angeles, California
- Los Angeles General Medical CenterLos Angeles, California
- USC Norris Comprehensive Cancer CenterLos Angeles, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: